当前位置: 首页 >> 检索结果
7369. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
作者: Rob W van der Pluijm.;Rupam Tripura.;Richard M Hoglund.;Aung Pyae Phyo.;Dysoley Lek.;Akhter Ul Islam.;Anupkumar R Anvikar.;Parthasarathi Satpathi.;Sanghamitra Satpathi.;Prativa Kumari Behera.;Amar Tripura.;Subrata Baidya.;Marie Onyamboko.;Nguyen Hoang Chau.;Yok Sovann.;Seila Suon.;Sokunthea Sreng.;Sivanna Mao.;Savuth Oun.;Sovannary Yen.;Chanaki Amaratunga.;Kitipumi Chutasmit.;Chalermpon Saelow.;Ratchadaporn Runcharern.;Weerayuth Kaewmok.;Nhu Thi Hoa.;Ngo Viet Thanh.;Borimas Hanboonkunupakarn.;James J Callery.;Akshaya Kumar Mohanty.;James Heaton.;Myo Thant.;Kripasindhu Gantait.;Tarapada Ghosh.;Roberto Amato.;Richard D Pearson.;Christopher G Jacob.;Sónia Gonçalves.;Mavuto Mukaka.;Naomi Waithira.;Charles J Woodrow.;Martin P Grobusch.;Michele van Vugt.;Rick M Fairhurst.;Phaik Yeong Cheah.;Thomas J Peto.;Lorenz von Seidlein.;Mehul Dhorda.;Richard J Maude.;Markus Winterberg.;Nguyen Thanh Thuy-Nhien.;Dominic P Kwiatkowski.;Mallika Imwong.;Podjanee Jittamala.;Khin Lin.;Tin Maung Hlaing.;Kesinee Chotivanich.;Rekol Huy.;Caterina Fanello.;Elizabeth Ashley.;Mayfong Mayxay.;Paul N Newton.;Tran Tinh Hien.;Neena Valecha.;Frank Smithuis.;Sasithon Pukrittayakamee.;Abul Faiz.;Olivo Miotto.;Joel Tarning.;Nicholas P J Day.;Nicholas J White.;Arjen M Dondorp.; .
来源: Lancet. 2020年395卷10233期1345-1360页
Artemisinin and partner-drug resistance in Plasmodium falciparum are major threats to malaria control and elimination. Triple artemisinin-based combination therapies (TACTs), which combine existing co-formulated ACTs with a second partner drug that is slowly eliminated, might provide effective treatment and delay emergence of antimalarial drug resistance.
7371. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
作者: Fei Zhou.;Ting Yu.;Ronghui Du.;Guohui Fan.;Ying Liu.;Zhibo Liu.;Jie Xiang.;Yeming Wang.;Bin Song.;Xiaoying Gu.;Lulu Guan.;Yuan Wei.;Hui Li.;Xudong Wu.;Jiuyang Xu.;Shengjin Tu.;Yi Zhang.;Hua Chen.;Bin Cao.
来源: Lancet. 2020年395卷10229期1054-1062页
Since December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Epidemiological and clinical characteristics of patients with COVID-19 have been reported but risk factors for mortality and a detailed clinical course of illness, including viral shedding, have not been well described.
7375. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.
作者: Huijun Chen.;Juanjuan Guo.;Chen Wang.;Fan Luo.;Xuechen Yu.;Wei Zhang.;Jiafu Li.;Dongchi Zhao.;Dan Xu.;Qing Gong.;Jing Liao.;Huixia Yang.;Wei Hou.;Yuanzhen Zhang.
来源: Lancet. 2020年395卷10226期809-815页
Previous studies on the pneumonia outbreak caused by the 2019 novel coronavirus disease (COVID-19) were based on information from the general population. Limited data are available for pregnant women with COVID-19 pneumonia. This study aimed to evaluate the clinical characteristics of COVID-19 in pregnancy and the intrauterine vertical transmission potential of COVID-19 infection.
7377. Are high-performing health systems resilient against the COVID-19 epidemic?
作者: Helena Legido-Quigley.;Nima Asgari.;Yik Ying Teo.;Gabriel M Leung.;Hitoshi Oshitani.;Keiji Fukuda.;Alex R Cook.;Li Yang Hsu.;Kenji Shibuya.;David Heymann.
来源: Lancet. 2020年395卷10227期848-850页 7379. SARS-CoV-2 is an appropriate name for the new coronavirus.
作者: Yuntao Wu.;Wenzhe Ho.;Yaowei Huang.;Dong-Yan Jin.;Shiyue Li.;Shan-Lu Liu.;Xuefeng Liu.;Jianming Qiu.;Yongming Sang.;Qiuhong Wang.;Kwok-Yung Yuen.;Zhi-Ming Zheng.
来源: Lancet. 2020年395卷10228期949-950页 |